Buy cheap generic or brand Zyrtec (Cetirizine) at one of the reputable online pharmacy. No prescription is needed! Worldwide delivery.

This medication is an antihistamine and decongestant combination which provides relief of seasonal and perennial allergy symptoms such as watery eyes, runny nose, itching eyes, sneezing, and stuffy nose. This medication is not recommended for use in children under 12 years of age due to the high amount of pseudoephedrine that may cause adverse effects to minors.

Despite of all the debate over the use of cough and cold medicines in children under the age of 12, sales of cough and cold medicines didn’t do too badly last year. For the 52 weeks of sales of all cough-cold remedies including: cough drops, cold-allergy liquids, cough syrups and cold-allergy tablets-went up to 10.5 % totaling $ 4 Billion across food and drug outlets according to Information Resources Inc. data. The increase of the sales was because of the latest allergy reliever to make its way from prescription vials to over-the-counter aisles. Zyrtec generated in excess of $ 331 million dollars across its Zyrtec tablet, Zyrtec syrup and Zyrtec D tablet.

Zyrtec tablets have fastly climbed to the top position in sales of cough-cold-allergy-sinus tablets, generating $248.9 million. Zyrtec-D, now formulated with pseudoephedrine and sold behind the pharmacy counter, generated an additional $57.4 million, and the liquid formulation of Zyrtec accounted for an added $24.9 million.

"The launch of Zyrtec was a powerful example of how we used experience and knowledge in both our pharmaceuticals and consumer businesses to help with the largest prescription to over-the-counter switch in our history," according to Bill Weldon, chairman and CEO of Johnson & Johnson, parent company to McNeil Consumer Healthcare.

McNeil Consumer Healthcare recently announced the availability of Children's Zyrtec Allergy Bubble Gum Syrup, dye-free, bubblegum-flavored and a new sugar-free, product used to treat upper respiratory allergies in children ages 2 years and older. The new formulation received approval from the FDA in August 2008.